US Patent Issued to MOR RESEARCH APPLICATIONS on July 15 for "Transthyretin antibodies and uses thereof" (Israeli Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,973, issued on July 15, was assigned to MOR RESEARCH APPLICATIONS LTD. (Ramat Gan, Israel).

"Transthyretin antibodies and uses thereof" was invented by Michael Fassler (Ness Ziona, Israel) and Jacob George (Tel Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human transthyretin (TTR). The anti-TTR antibodies or antigen-binding fragments thereof are useful, for example, in detecting TTR and in treating TTR amyloidosis in a subject."

The patent was filed on June 10, 2024, under Application No. 18/738,824.

*For further information, i...